10x Genomics to Report Second Quarter 2025 Financial Results on August 7, 2025

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the second quarter ended June 30, 2025 after market close on Thursday, August 7, 2025. The company will host a public conference call and live webcast for analysts and investors beginning at 1:30 p.m. Pacific […]

Chinola Fresh Fruit Liqueurs Expands Distribution with Southern Glazer’s Wine & Spirits Travel Retail Sales & Export Division

A strategic agreement poised to accelerate Chinola's global footprint across key export and travel retail markets. Chinola Fresh Fruit Liqueurs-the natural, low-ABV, artificial additive-free liqueurs made from 100% fresh fruit and neutral cane spirits-announces the expansion of its distribution into the Caribbean, Central America and travel retail through a new agreement with Southern Glazer's Wine

Appian To Announce Second Quarter 2025 Financial Results on August 7, 2025

Appian To Announce Second Quarter 2025 Financial Results on August 7, 2025 GlobeNewswire July 10, 2025 MCLEAN, Va., July 10, 2025 (GLOBE NEWSWIRE) — Appian (NASDAQ: APPN) today announced that it will release financial results for the second quarter ended June 30, 2025 before the U.S. financial markets open on Thursday, August 7, 2025. The

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date June 30, 2025

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date June 30, 2025 GlobeNewswire July 10, 2025 NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) — At the end of the settlement date of June 30, 2025, short interest in 3,257 Nasdaq Global MarketSM securities totaled 14,138,758,851 shares compared with 13,689,191,607 shares

Alignment Healthcare to Announce Second Quarter 2025 Financial Results and Host Conference Call Wednesday, July 30, 2025

Alignment Healthcare to Announce Second Quarter 2025 Financial Results and Host Conference Call Wednesday, July 30, 2025 GlobeNewswire July 10, 2025 ORANGE, Calif., July 10, 2025 (GLOBE NEWSWIRE) — Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its second quarter 2025 financial results on Wednesday, July 30, after market close. Following the release, the company will

LPL Financial Announces Second Quarter 2025 Earnings Release Date and Conference Call

LPL Financial Announces Second Quarter 2025 Earnings Release Date and Conference Call GlobeNewswire July 10, 2025 SAN DIEGO, July 10, 2025 (GLOBE NEWSWIRE) — LPL Financial Holdings Inc. (Nasdaq: LPLA) (the “Company”), the parent corporation of LPL Financial LLC, announced today it will report second quarter financial results after the market closes on Thursday, July

Exponent to Announce Second Quarter of Fiscal Year 2025 Results and Host Quarterly Conference Call on July 31, 2025

Exponent to Announce Second Quarter of Fiscal Year 2025 Results and Host Quarterly Conference Call on July 31, 2025 GlobeNewswire July 10, 2025 MENLO PARK, Calif., July 10, 2025 (GLOBE NEWSWIRE) — Exponent, Inc. (Nasdaq: EXPO), today announced that it will report Second Quarter of fiscal year 2025 financial results for the period ended July

UFC GYM Selects MMA.INC’s BJJLink.com Software as the Technology Engine to Power its Global Brazilian Jiu Jitsu (BJJ) Franchise Growth

UFC GYM Selects MMA.INC's BJJLink.com Software as the Technology Engine to Power its Global Brazilian Jiu Jitsu (BJJ) Franchise Growth GlobeNewswire July 10, 2025 Highlights Landmark multi-year agreement strengthens UFC GYM and MMA.INC alliance, supporting the global rollout of 45 new gyms in 2025 and accelerating the expansion of UFC GYM's high-growth BJJ program–powered by

Rapid7 to Report Second Quarter 2025 Financial Results on August 7

Rapid7 to Report Second Quarter 2025 Financial Results on August 7 GlobeNewswire July 10, 2025 BOSTON, July 10, 2025 (GLOBE NEWSWIRE) — Rapid7, Inc. (NASDAQ: RPD), a leader in threat detection and exposure management, today announced that the company will release its second quarter 2025 financial results on Thursday, August 7, 2025, after the financial

Maze Therapeutics to Participate in Two Upcoming Investor Conferences

Maze Therapeutics to Participate in Two Upcoming Investor Conferences GlobeNewswire July 10, 2025 SOUTH SAN FRANCISCO, Calif., July 10, 2025 (GLOBE NEWSWIRE) — Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company developing small molecule precision medicines for patients with renal, metabolic and cardiovascular diseases, today announced that company management will participate in fireside chats

Scroll to Top